EBITDA for DaVita (DVA)
According to DaVita's latest reported financial statements, the company's current EBITDA (TTM) is $2.64B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DVA
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$2.64B
YoY change
-3.0%
5Y CAGR
+3.2%
Peak year (2016)
$2.76B
Cumulative EBITDA
$42.27B
EBITDA history chart for DaVita (DVA) from 1994 to 2025
EBITDA history table for DaVita (DVA) from 1994 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $2.64B | -3.0% | ||
| 2024 | $2.72B | +17.4% | ||
| 2023 | $2.32B | +12.9% | ||
| 2022 | $2.06B | -17.2% | ||
| 2021 | $2.48B | +10.3% | ||
| 2020 | $2.25B | -0.1% | ||
| 2019 | $2.25B | +6.0% | ||
| 2018 | $2.13B | -18.4% | ||
| 2017 | $2.61B | -5.4% | ||
| 2016 | $2.76B | +59.0% | ||
| 2015 | $1.73B | -24.9% | ||
| 2014 | $2.31B | +10.9% | ||
| 2013 | $2.08B | +27.5% | ||
| 2012 | $1.63B | +14.6% | ||
| 2011 | $1.43B | +23.1% | ||
| 2010 | $1.16B | -1.3% | ||
| 2009 | $1.17B | +6.8% | ||
| 2008 | $1.10B | +4.0% | ||
| 2007 | $1.06B | +15.7% | ||
| 2006 | $912.73M | +56.0% | ||
| 2005 | $585.09M | +25.1% | ||
| 2004 | $467.79M | +7.6% | ||
| 2003 | $434.62M | -3.1% | ||
| 2002 | $448.49M | +7.8% | ||
| 2001 | $416.07M | +43.0% | ||
| 2000 | $290.88M | +54.5% | ||
| 1999 | $188.30M | -37.9% | ||
| 1998 | $303.40M | +83.7% | ||
| 1997 | $165.20M | +56.3% | ||
| 1996 | $105.70M | +218.4% | ||
| 1995 | $33.20M | +51.6% | ||
| 1994 | $21.90M | — |
EBITDA values are taken from DaVita's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of DaVita (DVA) EBITDA is $2.64B – edged down 3.0% year-over-year.
Over 2020–2025 (5 years), DaVita EBITDA expanded at a +3.2% compound annual rate, with the latest reading among the more recent periods of the dataset.
DaVita EBITDA peaked at $2.76B in 2016; the latest annual figure is $2.64B in 2025 (4.2% below peak).
Across the available history, EBITDA reached its high of $2.76B in 2016 and its low of $21.90M in 1994.
Within Healthcare, DaVita (DVA) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
DaVita EBITDA by Year
DaVita EBITDA 2025: $2.64B
DaVita EBITDA in 2025 was $2.64B, edged down 3.0% below 2024.
DaVita EBITDA 2024: $2.72B
DaVita EBITDA in 2024 was $2.72B, grew 17.4% from 2023.
DaVita EBITDA 2023: $2.32B
DaVita EBITDA in 2023 was $2.32B, grew 12.9% from 2022.
DaVita EBITDA 2022: $2.06B
DaVita EBITDA in 2022 was $2.06B, declined 17.2% below 2021.
DaVita EBITDA 2021: $2.48B
DaVita EBITDA in 2021 was $2.48B.
See more financial history for DaVita (DVA).
Sector peers — EBITDA
Companies in the same sector as DaVita, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is DaVita's EBITDA?
- Latest reported EBITDA for DaVita (DVA) is $2.64B (period ending December 31, 2025).
How has DaVita EBITDA changed year-over-year?
- DaVita (DVA) EBITDA changed -3.0% year-over-year on the latest annual filing.
What is the long-term growth rate of DaVita EBITDA?
- DaVita (DVA) EBITDA compound annual growth rate is +3.2% over the most recent 5 years available.
When did DaVita EBITDA hit its highest annual value?
- DaVita EBITDA reached its highest annual value of $2.76B in 2016.
What was DaVita EBITDA in 2024?
- DaVita (DVA) EBITDA in 2024 was $2.72B.
What was DaVita EBITDA in 2025?
- DaVita (DVA) EBITDA in 2025 was $2.64B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DVA Overview
Company profile, financial tools, and key metrics
DVA Revenue Counter
Earns $432.62 every second. See per minute, hour, and day.
DVA Earnings Counter
Earns $23.68 per second net profit. See per minute, hour, and day.
DVA Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
DVA What If Invested
What if you had invested $1,000? See historical returns from any date.
DVA How It Makes Money
Discover visual breakdown of $13.64B in revenue — where it comes from and where it goes.
DVA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DVA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DVA Daily Price Character
Balanced · 50.5% historical win rate (green days). Streaks & record days.
DVA Buybacks
18.33% TTM buyback yield. Shareholder yield & SBC comparison.
DVA Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.